Innovex [INVX] vs NextDecade [NEXT] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Innovex wins in 11 metrics, NextDecade wins in 3 metrics, with 0 ties. Innovex appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Innovex NextDecade Better
P/E Ratio (TTM) 9.09 57.21 Innovex
Price-to-Book Ratio 1.32 7.45 Innovex
Debt-to-Equity Ratio 9.91 285.00 Innovex
PEG Ratio -0.11 0.74 Innovex
EV/EBITDA 9.12 -43.70 NextDecade
Profit Margin (TTM) 16.66% 0.00% Innovex
Operating Margin (TTM) 12.45% 0.00% Innovex
EBITDA Margin (TTM) 12.45% N/A N/A
Return on Equity 21.44% -14.47% Innovex
Return on Assets (TTM) 7.25% -2.00% Innovex
Free Cash Flow (TTM) $79.85M $-2.66B Innovex
1-Year Return 19.54% 20.78% NextDecade
Price-to-Sales Ratio (TTM) 1.51 N/A N/A
Enterprise Value $1.35B $8.71B NextDecade
EV/Revenue Ratio 1.56 N/A N/A
Gross Profit Margin (TTM) 31.98% N/A N/A
Revenue per Share (TTM) $13 $0 Innovex
Earnings per Share (Diluted) $2.10 $-0.79 Innovex
Beta (Stock Volatility) N/A 1.79 N/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Innovex vs NextDecade Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Innovex-5.90%-8.46%2.99%5.78%19.35%18.94%
NextDecade-5.00%-8.24%-20.15%-29.86%-5.83%-22.17%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Innovex19.54%-10.61%-25.89%-71.73%-72.28%-6.59%
NextDecade20.78%14.67%158.56%-31.31%-31.80%-31.80%

News Based Sentiment: Innovex vs NextDecade

Innovex

News based Sentiment: POSITIVE

October was a significant month for Innovex International, highlighted by a major facility sale, a key partnership, and a positive stock price reaction. These developments suggest a positive shift in the company's trajectory and improved investor sentiment.

View Innovex News Sentiment Analysis

NextDecade

News based Sentiment: MIXED

October presented a mixed bag for NextDecade, with stock declines offset by bullish options activity and significant insider purchases. The upcoming earnings release on November 6th is a key catalyst that will likely determine the stock's direction, making this a significant month for investors.

View NextDecade News Sentiment Analysis

Performance & Financial Health Analysis: Innovex vs NextDecade

MetricINVXNEXT
Market Information
Market Cap i$1.30B$1.74B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i373,5734,289,940
90 Day Avg. Volume i350,5415,085,313
Last Close$17.21$6.46
52 Week Range$11.93 - $19.64$5.10 - $12.12
% from 52W High-12.37%-46.70%
All-Time High$121.07 (Oct 21, 2013)$20.00 (Jul 24, 2017)
% from All-Time High-85.79%-67.70%
Growth Metrics
Quarterly Revenue Growth0.72%N/A
Quarterly Earnings Growth0.61%N/A
Financial Health
Profit Margin (TTM) i0.17%0.00%
Operating Margin (TTM) i0.12%0.00%
Return on Equity (TTM) i0.21%-0.14%
Debt to Equity (MRQ) i9.91285.00
Cash & Liquidity
Book Value per Share (MRQ)$14.48$1.00
Cash per Share (MRQ)$1.10$0.61
Operating Cash Flow (TTM) i$148.37M$-145,468,992
Levered Free Cash Flow (TTM) i$-139,353,120$-2,732,655,616
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Innovex vs NextDecade

MetricINVXNEXT
Price Ratios
P/E Ratio (TTM) i9.0957.21
Forward P/E i24.79-7.37
PEG Ratio i-0.110.74
Price to Sales (TTM) i1.51N/A
Price to Book (MRQ) i1.327.45
Market Capitalization
Market Capitalization i$1.30B$1.74B
Enterprise Value i$1.35B$8.71B
Enterprise Value Metrics
Enterprise to Revenue i1.56N/A
Enterprise to EBITDA i9.12-43.70
Risk & Other Metrics
Beta iN/A1.79
Book Value per Share (MRQ) i$14.48$1.00

Financial Statements Comparison: Innovex vs NextDecade

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)INVXNEXT
Revenue/Sales i$240.42M$0
Cost of Goods Sold i$163.91M$3.15M
Gross Profit i$76.50M$-3.15M
Research & Development iN/A$307,000
Operating Income (EBIT) i$29.21M$-51.92M
EBITDA i$47.30M$-64.54M
Pre-Tax Income i$21.36M$-245.23M
Income Tax i$6.61MN/A
Net Income (Profit) i$14.76M$-245.23M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)INVXNEXT
Cash & Equivalents i$68.12M$130.94M
Total Current Assets i$632.64M$404.79M
Total Current Liabilities i$145.82M$475.68M
Long-Term Debt i$65.64M$4.69B
Total Shareholders Equity i$978.38M$1.72B
Retained Earnings i$225.38M$-542.33M
Property, Plant & Equipment i$78.27M$173.16M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)INVXNEXT
Operating Cash Flow i$49.08M$-218.51M
Capital Expenditures i$1.00M$-769.97M
Free Cash Flow i$24.03M$-838.80M
Debt Repayment i$-91.91M$0
Common Stock Repurchase i$-626,000N/A

Short Interest & Institutional Ownership Analysis

MetricINVXNEXT
Shares Short i2.80M10.80M
Short Ratio i9.192.55
Short % of Float i0.07%0.07%
Average Daily Volume (10 Day) i373,5734,289,940
Average Daily Volume (90 Day) i350,5415,085,313
Shares Outstanding i69.18M260.29M
Float Shares i37.92M117.00M
% Held by Insiders i0.03%0.25%
% Held by Institutions i1.05%0.49%

Dividend Analysis & Yield Comparison: Innovex vs NextDecade

MetricINVXNEXT
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A